Product

WX-081

1 clinical trial

1 indication

Indication

Clinical trial

A Multi-center, Randomized, Positive-controlled Phase 2 Clinical Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of WX-081 in Participants With Drug-naive&Susceptible or Drug-Resistant Pulmonary Tuberculosis

Status: Completed, Estimated PCD: 2022-04-13